Intrommune Therapeutics is developing oral mucosal immunotherapy to treat food allergies, using a novel toothpaste-based delivery mechanism for safe and convenient at-home treatment.
Halomine develops sustainable antimicrobial surface coatings that provide long-lasting protection against pathogens including bacteria and viruses in healthcare and public environments.
TET Medical develops innovative cardiac devices for the treatment of arrhythmias and heart failure, focusing on minimally invasive solutions that improve patient outcomes and quality of life.
Rancho Santa Fe Bio was a biotechnology company developing novel therapeutic approaches. The company achieved a successful exit following the advancement of its lead research programs.
Celestial Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics targeting inflammatory and fibrotic diseases with significant unmet medical needs.
Saferide Health is a non-emergency medical transportation management company that coordinates rides for Medicaid and Medicare patients, improving access to care and reducing missed appointments.
Repairogen was a regenerative medicine company developing therapies to promote tissue repair and healing, targeting conditions with limited treatment options and significant patient burden.
Alva Health delivers personalized digital therapeutics for menopause, combining clinical expertise with technology to improve quality of life for women navigating hormonal transitions.
One Three Biotech uses machine learning and genomic data to accelerate drug discovery, identifying novel therapeutic targets and predicting drug response to shorten development timelines.
Twiage developed a mobile communication platform connecting paramedics and emergency departments to streamline pre-hospital data sharing and improve care coordination for incoming patients.
